The Effects of Mandatory ESG Disclosure Around the World
Journal of Accounting Research · 2024-12 · 62 (5) · 1795-1847
DOI: 10.1111/1475-679x.12548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Accounting Research, online erschienen am 04.05.2024. Verfasst von PHILIPP KRUEGER und 3 weiteren Autor:innen. Die Arbeit wurde bisher 576-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Office for Philosophy and Social Sciences.
Abstract (Originalsprache)
We compile a novel data set on mandatory environmental, social, and governance (ESG) disclosure around the world to analyze the stock liquidity effects of such disclosure mandates. We document a positive effect of ESG disclosure mandates on firm‐level stock liquidity. The effects are strongest if the disclosure requirements are implemented by government institutions, not on a comply‐or‐explain basis, and coupled with strong enforcement by informal institutions. Firms with weaker information environments benefit more from ESG disclosure mandates. Our results support the view that ESG disclosure regulation improves the information environment and has beneficial capital market effects.
Förderung
- National Office for Philosophy and Social Sciences
Zitieren
APA
KRUEGER, P., SAUTNER, Z., TANG, D. Y., & ZHONG, R. (2024). The Effects of Mandatory ESG Disclosure Around the World. Journal of Accounting Research, 62(5), 1795-1847. https://doi.org/10.1111/1475-679x.12548
Vancouver
KRUEGER P, SAUTNER Z, TANG DY, ZHONG R. The Effects of Mandatory ESG Disclosure Around the World. Journal of Accounting Research. 2024;62(5):1795-1847. doi:10.1111/1475-679x.12548
BibTeX
@article{KRUEGER2024,
author = {KRUEGER, PHILIPP and SAUTNER, ZACHARIAS and TANG, DRAGON YONGJUN and ZHONG, RUI},
title = {The Effects of Mandatory ESG Disclosure Around the World},
journal = {Journal of Accounting Research},
year = {2024},
volume = {62},
number = {5},
pages = {1795--1847},
doi = {10.1111/1475-679x.12548}
}
EUVIMED